Lomustine After First-Line Therapy for Glioblastoma Multiforme (GBM)Presenter: Sandra Silberman, MD, PhD, Chief Medical Officer of CNS PharmaceuticalsProgram Code: CTNI-68Category: Poster and ...
For more information about SNO 2024, please visit the conference website. About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of ...
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果